Jul 22 2009
GlaxoSmithKline Completes Acquisition of Stiefel

Jun 2 2009
Stiefel Laboratories reaps first fruits of Barrier acquisition with completion of pivotal phase III clinical trial for 200 mg Hyphanox™ (itraconazole) tablet

Apr 20 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business

Mar 6 2009
Stiefel Laboratories Expands U.S. Consumer HealthCare Division: Launches Impruv® Dry Skin Product Line At Walgreens

Dec 4 2008
Stiefel Laboratories Announces The Expansison Of Its REVALÉSKIN® Skin Care Line With Three New Products

Oct 20 2008
Bob Cunard appointed President of Glades Pharmaceuticals

Aug 6 2008
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics

Aug 5 2008
Stiefel Laboratories, Inc. Successfully Completes Tender Offer For Shares Of Barrier Therapeutics, Inc.